Skip to content
Search

Latest Stories

Alloga UK delivers nearly 25 million Covid-19 vaccines

Alloga UK, leading healthcare logistics provider, said it has delivered 24.6 million doses of Covid-19 vaccine till date across England, playing an instrumental role in supporting the NHS.

With the support from colleagues across Alliance Healthcare, its parent firm, Alloga teams have delivered vaccines to approximately 1,490 sites since last December, with deliveries taking place up to seven days a week.


“Our unrivalled experience in vaccine distribution has informed our approach and allowed us to work at pace with NHSE in designing and implementing this very complex supply chain within such a short period of time,” Chris Williams, managing director of Alloga UK, commented.

As part of the programme, Williams led a dedicated team that ensured all necessary processes and preparations were accommodated to distribute vaccines. This involved an area of the Alloga facility being cordoned off and privatised to keep the operation classified. The site was also visited numerous times by Government appointed security agencies to ensure safety and security of the vaccines’ storage.

Alloga Fridges Fridges for sub-zero storage at Alloga facility

“This implementation has been far from easy, but our professional teams coupled with a can-do mentality have allowed us to overcome many logistics challenges and implement an excellent solution. The teams across NHSE, Alloga UK and Alliance Healthcare UK should be justifiably proud of their collective achievement,” Williams said.

Alloga said it has achieved 99.5 per cent delivery on time and in full. It currently delivers to 982 live sites.

Julian Mount, managing director of Alliance Healthcare UK, added: “I am so proud that our business and our colleagues are playing such a key part in the lifesaving effort of Covid-19 vaccine distribution. Team members from multiple departments across the business, have all come together to support this national effort. I want to personally thank each and every one who has been involved. It is a fantastic joint endeavour, and it is just one more example of how Alliance Healthcare and Alloga are working together to support the NHS and patients across the UK.”

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less